Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hypertension

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 24 articles: HTML format

Single Articles

June 2023
1. ZHAO X, Chen Y, Yang G, Li X, et al
   Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
   Am Heart J. 2023 Jun 3:S0002-8703(23)00142-4. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   April 2023
2. DA FONSECA SF, Pinho Ribeiro AL, Rodrigues Cimini CC, de Castro Soares TB, et al
   Scale up of implementation of a multidimensional intervention to enhance hypertension and diabetes care at the primary care setting: a protocol for a cluster-randomized study in Brazil.
   Am Heart J. 2023 Apr 10:S0002-8703(23)00092-3. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
3. FU G, Zhou Z, Jian B, Huang S, et al
   Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
   Am Heart J. 2023;258:177-185.
   PubMed     Abstract available
   
   
   
4. FANAROFF AC, Coratti S, Halaby R, Sanghavi M, et al
   Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial.
   Am Heart J. 2023;258:85-95.
   PubMed     Abstract available
   
   
   January 2023
5. WU Q, Ye Z, Zhou C, Liu M, et al
   A U-shaped association between dietary phosphorus intake and new-onset hypertension: A nationwide cohort study in China.
   Am Heart J. 2023 Jan 20:S0002-8703(23)00020-0. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
6. GREEN MD, Dalmage MR, Lusk JB, Kadhim EF, et al
   Public Reporting of Black Participation in Anti-Hypertensive Drug Clinical Trials.
   Am Heart J. 2023 Jan 11:S0002-8703(23)00001-7. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
7. LAUFFENBURGER JC, Khatib R, Siddiqi A, Albert MA, et al
   Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design.
   Am Heart J. 2023;255:12-21.
   PubMed     Abstract available
   
   
   December 2022
8. BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
   Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
   Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
   PubMed     Abstract available
   
   
   
9. LIU J, Wang B, Li Y, Yan X, et al
   Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
   Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
   PubMed     Abstract available
   
   
   October 2022
10. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    PubMed     Abstract available
    
    
    September 2022
11. BALDRIDGE AS, Huffman MD, Lazar D, Abbas H, et al
    Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA): Rationale and Design for a Randomized Controlled Trial.
    Am Heart J. 2022 Sep 15. pii: S0002-8703(22)00189.
    PubMed     Abstract available
    
    
    August 2022
12. WANG SY, Hanna JM, Gongal P, Onuma O, et al
    Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial.
    Am Heart J. 2022 Aug 3. pii: S0002-8703(22)00157.
    PubMed     Abstract available
    
    
    July 2022
13. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    PubMed     Abstract available
    
    
    
14. MACEDO AVS, de Barros E Silva PGM, de Paula TC, Moll-Bernardes RJ, et al
    Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial.
    Am Heart J. 2022;249:86-97.
    PubMed     Abstract available
    
    
    June 2022
15. MAGANJA D, Trieu K, Reading M, Huang L, et al
    Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping (OGS) randomised trial.
    Am Heart J. 2022 Jun 28. pii: S0002-8703(22)00131.
    PubMed     Abstract available
    
    
    May 2022
16. HENDRIKS PM, van de Groep LD, Veen KM, van Thor MCJ, et al
    Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00093.
    PubMed     Abstract available
    
    
    
17. SHAH NP, Clare RM, Chiswell K, Navar AM, et al
    Trends of blood pressure control in the U.S. during the COVID-19 pandemic.
    Am Heart J. 2022;247:15-23.
    PubMed     Abstract available
    
    
    April 2022
18. KAZE AD, Gao X, Musani SK, Bidulescu A, et al
    Association of plasma endothelin-1 with blood pressure progression among Blacks: The Jackson Heart Study.
    Am Heart J. 2022;246:144-151.
    PubMed     Abstract available
    
    
    October 2021
19. ZHEUTLIN AR, Derington CG, King JB, Berchie RO, et al
    Factors Associated with Antihypertensive Monotherapy Among US Adults with Treated Hypertension and Uncontrolled Blood Pressure Overall and by Race/Ethnicity, NHANES 2013-2018.
    Am Heart J. 2021 Oct 15. pii: S0002-8703(21)00436.
    PubMed     Abstract available
    
    
    
20. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    PubMed     Abstract available
    
    
    
21. SANDHU AT, Kohsaka S, Lin S, Woo CY, et al
    Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
    Am Heart J. 2021;240:46-57.
    PubMed     Abstract available
    
    
    July 2021
22. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    PubMed     Abstract available
    
    
    May 2021
23. MAHFOUD F, Weber M, Schmieder RE, Lobo MD, et al
    Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
    Am Heart J. 2021 May 27. pii: S0002-8703(21)00144.
    PubMed     Abstract available
    
    
    
24. STEVENS BR, Pepine CJ, Richards EM, Kim S, et al
    Depressive-hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
    Am Heart J. 2021 May 10:100540. doi: 10.1016/j.ahj.2021.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: